Synergy between VEGF/VEGFR inhibitors and chemotherapy agents in the phase I clinic.
Tang, Chad
Synergy between VEGF/VEGFR inhibitors and chemotherapy agents in the phase I clinic. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Dec 2014 - 5956-63 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
1557-3265
10.1158/1078-0432.CCR-14-1582 doi
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Child
Child, Preschool
Drug Synergism
Female
Humans
Male
Middle Aged
Mutation
Neoplasms--diagnosis
Odds Ratio
Protein Kinase Inhibitors--administration & dosage
Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors
Treatment Outcome
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Young Adult
Synergy between VEGF/VEGFR inhibitors and chemotherapy agents in the phase I clinic. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Dec 2014 - 5956-63 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
1557-3265
10.1158/1078-0432.CCR-14-1582 doi
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Child
Child, Preschool
Drug Synergism
Female
Humans
Male
Middle Aged
Mutation
Neoplasms--diagnosis
Odds Ratio
Protein Kinase Inhibitors--administration & dosage
Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors
Treatment Outcome
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Young Adult